Phase I study of a 120-hour continuous intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid tumors: a Pediatric Oncology Group study.

Green, D M; Krischer, J P; Bell, B; Brecher, M L; Cushing, B; Whitehead, V M

Green, D M; Krischer, J P; Bell, B; Brecher, M L; Cushing, B; Whitehead, V M.

Affiliation

Green DM; Department of Pediatrics, Roswell Park Cancer Institute and School of Medicine, State University of New York, Buffalo.

Med Pediatr Oncol ; 18(4): 321-4, 1990.

Article in En | MEDLINE | ID: mdl-2355893

Subject(s)

Fluorouracil/administration & dosage; Neoplasms/drug therapy; Adolescent; Alanine Transaminase/blood; Alkaline Phosphatase/metabolism; Aspartate Aminotransferases/blood; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Fluorouracil/adverse effects; Gastrointestinal Diseases/chemically induced; Hematologic Diseases/chemically induced; Humans; Infusions, Intravenous; Recurrence

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Fluorouracil / Neoplasms Limits: Adolescent / Child / Humans Language: En Journal: Med Pediatr Oncol Year: 1990 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links